Abstract

Viral hepatitis, caused by hepatitis viruses A through E, still remains a major public health problem in India. AVH being most commonly encountered disease and the times it get takes for the recovery is quite questionable. The patient or parents of the child usually changes the doctors as and when there is change in the laboratory parameters. The phase of the hepatitis is divided in to the three phase where the early phase, mid phase and recovery phase. The early phase where the symptomatically patient has the high raise in the LFT parameter such as the SGOT and SGPT. The second phase where the transaminase starts settling down and the bilirubin starts increasing and transaminase starts settling down and later phase where the Bilirubin stay high and starts falling down and transaminase touches he baseline, overall procedure takes the 30-45 days for recovery in the patients. This study has been made to understand the pathophysiology of the acute viral hepatitis and its recovery takes the quite prolonged. The concept and the different phases of the acute viral hepatitis has been mentioned base on the textual and the clinical experience of the gastroenterologist.

• 1.   Alberts CJ, Boyd A, Bruisten SM, Heijman T, Hogewoning A, Rooijen MV, et al. Hepatitis A incidence, seroprevalence, and vaccination decision among MSM in Amsterdam, the Netherlands. Vaccine. 2019;37(21):2849–56.
• 2.   Johnson KD, Lu X, Zhang D. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study. BMC Public Health. 2019;19(1):404.
• 3.   Brennan J, Moore K, Sizemore L, Mathieson SA, Wester C, Dunn JR, et al. Notes from the field: acute hepatitis A virus infection among previously vaccinated persons with HIV infection — Tennessee, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(14):328–9.
• 4.   Wilson E, Hofmeister MG, McBee S, Briscoe J, Thomasson E, Olaisen RH, et al. Notes from the field: hepatitis A outbreak associated with drug use and homelessness — West Virginia, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(14):330–1.
• 5.   Tan EM, Marcelin JR, Virk A. Pre-travel counseling for immunocompromised travelers: a 12-year single-center retrospective review. Infect Dis Health. 2019;24(1):13–22.
• 6.   Nelson NP, Link-Gelles R, Hofmeister MG, Romero JR, Moore KL, Ward JW, et al. Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. MMWR Morb Mortal Wkly Rep. 2018;67(43):1216–20.
• 7.   Gervasi G, Biticchi M, Zaratti L, Franco E. [Epidemics of Hepatitis A and opportunities for vaccination: a focus on the category of men who practice sex with men (MSM)]. Ig Sanita Pubbl. 2018;74(3):295–304.
• 8.   Waszczuk K, Waszczuk E, Szenborn L. Can we better protect patients with inflammatory bowel disease against infections - patient attitude and personal immunization knowledge. Acta Gastroenterol Belg. 2018;81(2):257–61.
• 9.   O'Leary ST, Kimberlin DW. Update from the Advisory Committee on Immunization Practices. J Pediatric Infect Dis Soc. 2018;7(3):181–7.
• 10.   Singh V, Crosby RA, Gratzer B, Gorbach PM, Markowitz LE, Meites E. Disclosure of sexual behavior is significantly associated with receiving a panel of health care services recommended for men who have sex with men. Sex Transm Dis. 2018;45(12):803–7.
• 11.   Doshani M, Weng M, Moore KL, Romero JR, Nelson NP. Recommendations of the Advisory Committee on Immunization Practices for use of Hepatitis A vaccine for persons experiencing homelessness. MMWR Morb Mortal Wkly Rep. 2019;68(6):153–6.
• 12.   Tajammal R, Ali IA, Syed T, Nusrat S. Immunization against hepatitis A virus and hepatitis B virus in patients with chronic liver disease: are we doing a good job? Cureus. 2018;10(4):e2528.